CN100591667C - N-amino-1,2-cyclopentane dicarboximide and its preparation method - Google Patents
N-amino-1,2-cyclopentane dicarboximide and its preparation method Download PDFInfo
- Publication number
- CN100591667C CN100591667C CN200810060128A CN200810060128A CN100591667C CN 100591667 C CN100591667 C CN 100591667C CN 200810060128 A CN200810060128 A CN 200810060128A CN 200810060128 A CN200810060128 A CN 200810060128A CN 100591667 C CN100591667 C CN 100591667C
- Authority
- CN
- China
- Prior art keywords
- amino
- cyclopentane
- solvent
- preparation
- dicarboximide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
本发明公开了一种N-氨基-1,2-环戊烷二甲酰亚胺,其化学结构式为:(见右式)。本发明还公开了其制备方法:以环戊烷邻二甲酸酐为原料,于溶剂中与水合肼进行回流反应,反应时间为0.5~12小时,环戊烷邻二甲酸酐与水合肼的摩尔比=1∶1~2.5;反应结束后脱除溶剂,干燥,得到N-氨基-1,2-环戊烷二甲酰亚胺。本发明的N-氨基-1,2-环戊烷二甲酰亚胺能作为格列齐特的中间体,从而缩短格列齐特的反应路线,有效减少废弃物。
The invention discloses an N-amino-1,2-cyclopentane dicarboximide, whose chemical structural formula is: (see the formula on the right). The invention also discloses its preparation method: take cyclopentane phthalic anhydride as raw material, carry out reflux reaction with hydrazine hydrate in a solvent, the reaction time is 0.5 to 12 hours, the moles of cyclopentane phthalic anhydride and hydrazine hydrate Ratio=1:1~2.5; after the reaction, the solvent is removed and dried to obtain N-amino-1,2-cyclopentanedicarboximide. The N-amino-1,2-cyclopentane dicarboximide of the invention can be used as an intermediate of gliclazide, thereby shortening the reaction route of gliclazide and effectively reducing waste.
Description
技术领域 technical field
本发明涉及一种有机物N-氨基-1,2-环戊烷二甲酰亚胺及其化学合成方法。The invention relates to an organic substance N-amino-1,2-cyclopentane dicarboximide and its chemical synthesis method.
背景技术 Background technique
N-氨基-1,2-环戊烷二甲酰亚胺是制备格列齐特(Gliclazide)的关键中间体。格列齐特是第二代磺酰脲类口服降糖药,具有降血糖和改善凝血功能的双重作用,临床上被广泛使用。格列齐特的合成通常以环戊烷邻二甲酸亚胺为原料,在四氢呋喃中与LiAlH4反应,还原得到杂氮环(Griot,R.SiegfriedAkt.-Ges.,Zofingen,Switz.Helvetica Chimica Acta.1959,42:67-72);将此物质溶于醋酸中与亚硝酸钠反应得到N-亚硝基-3-氮杂二环辛烷,再经锌粉还原得到六氢-2-环戊并吡咯基胺(JP05065270A),最后与对甲苯磺酰脲缩合得到产品(JP06041073A)。反应过程如下:N-amino-1,2-cyclopentanedicarboximide is a key intermediate for the preparation of Gliclazide. Gliclazide is a second-generation sulfonylurea oral hypoglycemic drug, which has dual effects of lowering blood sugar and improving blood coagulation function, and is widely used clinically. The synthesis of gliclazide usually takes cyclopentane phthalic acid imide as raw material, reacts with LiAlH in tetrahydrofuran, and reduces to obtain the azacyclic ring (Griot, R.SiegfriedAkt.-Ges., Zofingen, Switz.Helvetica Chimica Acta .1959, 42:67-72); this substance was dissolved in acetic acid and reacted with sodium nitrite to obtain N-nitroso-3-azabicyclooctane, which was then reduced by zinc powder to obtain hexahydro-2-cyclo Penpyrrolylamine (JP05065270A), and finally condensed with p-toluenesulfonylurea to obtain the product (JP06041073A). The reaction process is as follows:
此反应过程的主要缺点是步骤繁琐,要经过4步反应才可以得到产品,反应成本高。The main disadvantage of this reaction process is that the steps are cumbersome, and the product can only be obtained through 4 steps of reaction, and the reaction cost is high.
发明内容Contents of the invention
本发明要解决的技术问题是提供一种N-氨基-1,2-环戊烷二甲酰亚胺及其制备方法,该N-氨基-1,2-环戊烷二甲酰亚胺能作为合成降血糖药物——格列齐特的中间体,从而缩短格列齐特的反应路线,有效减少废弃物。The technical problem to be solved in the present invention is to provide a kind of N-amino-1,2-cyclopentane dicarboximide and preparation method thereof, this N-amino-1,2-cyclopentane dicarboximide can As an intermediate in the synthesis of the hypoglycemic drug gliclazide, it can shorten the reaction route of gliclazide and effectively reduce waste.
为了解决上述技术问题,本发明提供一种N-氨基-1,2-环戊烷二甲酰亚胺,其化学结构式为:In order to solve the above technical problems, the invention provides a kind of N-amino-1,2-cyclopentane dicarboximide, its chemical structural formula is:
本发明还提供了N-氨基-1,2-环戊烷二甲酰亚胺的制备方法,以环戊烷邻二甲酸酐为原料,于溶剂中与水合肼进行回流反应,反应时间为0.5~12小时,环戊烷邻二甲酸酐与水合肼的摩尔比=1∶1~2.5;反应结束后脱除溶剂,干燥,得到N-氨基-1,2-环戊烷二甲酰亚胺。The present invention also provides a preparation method of N-amino-1,2-cyclopentanedicarboximide, which uses cyclopentane phthalic anhydride as raw material and reflux reaction with hydrazine hydrate in a solvent, and the reaction time is 0.5 ~12 hours, the molar ratio of cyclopentane phthalic anhydride to hydrazine hydrate=1:1~2.5; after the reaction, the solvent is removed and dried to obtain N-amino-1,2-cyclopentane dicarboximide .
作为本发明的制备方法的改进:先将环戊烷邻二甲酸酐放入溶剂中,然后将水合肼以滴加的形式加入溶剂中,所述滴加为常温或回流条件下滴加。As an improvement of the preparation method of the present invention: first put cyclopentane phthalic anhydride into the solvent, and then add hydrazine hydrate into the solvent in the form of dropwise addition, and the dropwise addition is at normal temperature or under reflux conditions.
作为本发明的制备方法的进一步改进:溶剂为水、醇类有机溶剂、酯类有机溶剂、除醇类和酯类外的其它有机溶剂与水的混合液、除醇类和酯类外的其它有机溶剂与醇类有机溶剂的混合液、或除醇类和酯类外的其它有机溶剂与酯类有机溶剂的混合液。醇类有机溶剂为甲醇、乙醇、丙醇、异丙醇、丁醇、异丁醇、乙二醇、二甘醇、环己醇或苄醇;酯类有机溶剂为乙酸乙酯、乙酸甲酯或乙酸丁酯。除醇类和酯类外的其它有机溶剂为烃类(例如为戊烷、己烷、环己烷、石油醚、苯、甲苯或二甲苯)、卤代烃(氯仿、二氯甲烷或二氯乙烷)、丙酮、丁酮环己酮或四氢呋喃。溶剂与环戊烷邻二甲酸酐的摩尔比为1~50∶1。As a further improvement of the preparation method of the present invention: the solvent is a mixture of water, alcohol organic solvents, ester organic solvents, other organic solvents except alcohols and esters and water, other organic solvents except alcohols and esters. A mixture of organic solvents and alcohol organic solvents, or a mixture of organic solvents other than alcohols and esters and ester organic solvents. Alcohol organic solvents are methanol, ethanol, propanol, isopropanol, butanol, isobutanol, ethylene glycol, diethylene glycol, cyclohexanol or benzyl alcohol; ester organic solvents are ethyl acetate, methyl acetate or butyl acetate. Other organic solvents besides alcohols and esters are hydrocarbons (such as pentane, hexane, cyclohexane, petroleum ether, benzene, toluene or xylene), halogenated hydrocarbons (chloroform, dichloromethane or dichloromethane) ethane), acetone, methyl ethyl ketone cyclohexanone or tetrahydrofuran. The molar ratio of solvent to cyclopentane phthalic anhydride is 1-50:1.
作为本发明的制备方法的进一步改进:水合肼为质量分数是25%~85%的水合肼水溶液。As a further improvement of the preparation method of the present invention: the hydrazine hydrate is an aqueous solution of hydrazine hydrate with a mass fraction of 25% to 85%.
本发明的反应方程式可表示为:Reaction equation of the present invention can be expressed as:
采用本发明的方法制备的产品经气相-质谱仪分析,确定了M=154的分子离子峰,以及M=98的丁二酰亚胺负离子碎片。经红外分析,在1707cm-1出现了酰胺羰基碳氧键(-C=O)的特征吸收峰,在3297cm-1、3174cm-1出现了氨基氮氢键(-N-H)的特征吸收峰,且为双峰,证明为伯胺。最终确定为N-氨基-1,2-环戊烷二甲酰亚胺。The product prepared by the method of the present invention is analyzed by a gas phase-mass spectrometer, and the molecular ion peak of M=154 and the succinimide anion fragment of M=98 are confirmed. Through infrared analysis, the characteristic absorption peak of amide carbonyl carbon-oxygen bond (-C=O) appeared at 1707cm -1 , and the characteristic absorption peak of amino nitrogen hydrogen bond (-NH) appeared at 3297cm -1 and 3174cm -1 , and For the doublet, proved to be primary amine. It was finally determined to be N-amino-1,2-cyclopentane dicarboximide.
将本发明的N-氨基-1,2-环戊烷二甲酰亚胺用于生产格列齐特,反应过程如下:N-amino-1,2-cyclopentane dicarboximide of the present invention is used for producing gliclazide, and the reaction process is as follows:
综上所述,采用本发明的N-氨基-1,2-环戊烷二甲酰亚胺生产格列齐特,缩短了反应步骤,并有利于环保降低生产成本;适于大规模的批量生产。In summary, adopting N-amino-1,2-cyclopentanedicarboximide of the present invention to produce gliclazide shortens the reaction steps, is beneficial to environmental protection and reduces production costs; it is suitable for large-scale batches Production.
具体实施方式 Detailed ways
下面结合具体实施例对本发明作进一步描述:The present invention will be further described below in conjunction with specific embodiment:
实施例1:一种N-氨基-1,2-环戊烷二甲酰亚胺的制备方法,依次进行以下步骤:Embodiment 1: A kind of preparation method of N-amino-1,2-cyclopentane dicarboximide, carries out following steps successively:
在装有回流冷凝管、机械搅拌的250mL三口烧瓶中,加入14g环戊烷邻二甲酸酐,50mL甲醇,加热至回流后,缓慢滴加7mL 85%的水合肼水溶液,滴加完毕后继续回流反应6小时。In a 250mL three-necked flask equipped with a reflux condenser and mechanical stirring, add 14g of cyclopentane phthalic anhydride and 50mL of methanol, after heating to reflux, slowly add 7mL of 85% hydrazine hydrate aqueous solution dropwise, and continue to reflux after the dropwise addition React for 6 hours.
反应结束后,停止加热,将反应液至旋转蒸发仪处减压蒸馏出溶剂及水,得到粘稠液体,冷却后得到产品N-氨基-1,2-环戊烷二甲酰亚胺,真空下于30℃干燥12小时,得到产品13.5g,收率为87.7%。After the reaction is over, stop heating, put the reaction solution to a rotary evaporator to distill off the solvent and water under reduced pressure to obtain a viscous liquid, and after cooling to obtain the product N-amino-1,2-cyclopentanedicarboximide, vacuum Dry at 30° C. for 12 hours to obtain 13.5 g of the product with a yield of 87.7%.
实施例2:一种N-氨基-1,2-环戊烷二甲酰亚胺的制备方法,依次进行以下步骤:Embodiment 2: A kind of preparation method of N-amino-1,2-cyclopentane dicarboximide, carries out following steps successively:
在装有回流冷凝管、机械搅拌的250mL三口烧瓶中,加入14g环戊烷邻二甲酸酐,50mL甲醇,常温下滴加7mL 85%的水合肼,滴加完毕后加热至回流,反应时间7小时。In a 250mL three-necked flask equipped with a reflux condenser and mechanical stirring, add 14g of cyclopentane phthalic anhydride, 50mL of methanol, and add 7mL of 85% hydrazine hydrate dropwise at room temperature. After the dropwise addition, it is heated to reflux, and the reaction time is 7 Hour.
反应结束后,停止加热,将反应液至旋转蒸发仪处减压蒸馏出溶剂及水,得到粘稠液体,冷却后得到产品N-氨基-1,2-环戊烷二甲酰亚胺,真空下于30℃干燥12小时,得到产品13.2g,收率为85.7%。After the reaction is over, stop heating, put the reaction solution to a rotary evaporator to distill off the solvent and water under reduced pressure to obtain a viscous liquid, and after cooling to obtain the product N-amino-1,2-cyclopentanedicarboximide, vacuum Dry at 30° C. for 12 hours to obtain 13.2 g of the product with a yield of 85.7%.
实施例3~11:改变上述实施例1或2中的溶剂、水合肼浓度以及水合肼用量、反应时间,可获得相应的实施例3~11。具体内容见表1,每个实施例所得的产品收率见表1。Embodiments 3-11: By changing the solvent, the concentration of hydrazine hydrate, the dosage of hydrazine hydrate, and the reaction time in the above-mentioned embodiment 1 or 2, corresponding embodiments 3-11 can be obtained. The specific content is shown in Table 1, and the product yield of each embodiment gained is shown in Table 1.
表1、实施例3~11的具体数据The concrete data of table 1, embodiment 3~11
实施例12、六氢-2-环戊并吡咯基胺的合成:Embodiment 12, the synthesis of hexahydro-2-cyclopentapyrrolylamine:
在装有回流冷凝管、机械搅拌的250mL三口烧瓶中,加入80mL四氢呋喃,预热至50℃左右加入25g三氯化铝,搅拌10min后加入12g硼氢化钾,再搅拌15min后加入15.4gN-氨基-1,2-环戊烷二甲酰亚胺,加热至回流,反应7小时。反应结束后冷却,用50×3mL甲苯萃取,萃取液加入盐酸,酸化至pH≈3,减压蒸馏出甲苯及少量水,得到产品盐酸盐,并用乙醇重结晶,得到产品的盐酸盐12.8g,收率为78.7%。In a 250mL three-necked flask equipped with a reflux condenser and mechanical stirring, add 80mL of tetrahydrofuran, preheat to about 50°C, add 25g of aluminum trichloride, stir for 10 minutes, add 12g of potassium borohydride, and then add 15.4g of N-amino -1,2-cyclopentane dicarboximide, heated to reflux, reacted for 7 hours. Cool down after the reaction, extract with 50×3mL toluene, add hydrochloric acid to the extract, acidify to pH ≈ 3, distill off toluene and a small amount of water under reduced pressure to obtain the product hydrochloride, and recrystallize with ethanol to obtain the product hydrochloride 12.8 g, the yield is 78.7%.
实施例13、格列齐特的合成:Embodiment 13, the synthesis of Gliclazide:
在装有回流冷凝管、机械搅拌的250mL三口烧瓶中,加入16.3g六氢-2-环戊并吡咯基胺的盐酸盐,22g对甲苯磺酰脲,100mL DMF,加热至回流,反应约2小时。反应结束滴加水100mL,冷却至10℃左右析出物料,过滤,适量水洗,得到产品格列齐特。真空下于80℃干燥12小时,得到产品28.2g,熔点为163.1~165.3℃,收率为87.2%。In a 250mL three-necked flask equipped with a reflux condenser and mechanical stirring, add the hydrochloride salt of 16.3g of hexahydro-2-cyclopentopyrrolylamine, 22g of p-toluenesulfonylurea, and 100mL of DMF, and heat to reflux, and the reaction is about 2 hours. At the end of the reaction, 100 mL of water was added dropwise, cooled to about 10°C to precipitate the material, filtered, and washed with appropriate amount of water to obtain the product gliclazide. It was dried at 80°C for 12 hours under vacuum to obtain 28.2g of the product with a melting point of 163.1-165.3°C and a yield of 87.2%.
最后,还需要注意的是,以上列举的仅是本发明的若干个具体实施例。显然,本发明不限于以上实施例,还可以有许多变形。本领域的普通技术人员能从本发明公开的内容直接导出或联想到的所有变形,均应认为是本发明的保护范围。Finally, it should be noted that the above examples are only some specific embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments, and many variations are possible. All deformations that can be directly derived or associated by those skilled in the art from the content disclosed in the present invention should be considered as the protection scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810060128A CN100591667C (en) | 2008-03-11 | 2008-03-11 | N-amino-1,2-cyclopentane dicarboximide and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810060128A CN100591667C (en) | 2008-03-11 | 2008-03-11 | N-amino-1,2-cyclopentane dicarboximide and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101235011A CN101235011A (en) | 2008-08-06 |
| CN100591667C true CN100591667C (en) | 2010-02-24 |
Family
ID=39918950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810060128A Expired - Fee Related CN100591667C (en) | 2008-03-11 | 2008-03-11 | N-amino-1,2-cyclopentane dicarboximide and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100591667C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102050778B (en) * | 2009-11-09 | 2012-09-05 | 浙江九洲药业股份有限公司 | Method for synthesizing gliclazide and intermediate thereof |
| CN102382034B (en) * | 2010-09-06 | 2013-03-27 | 山东方明药业集团股份有限公司 | Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride |
| CN103183632A (en) * | 2011-12-29 | 2013-07-03 | 山东方明药业集团股份有限公司 | Purification method of 3-azabicyclo-octane hydrochloride |
| CN102584677B (en) * | 2012-02-07 | 2014-01-08 | 安徽金鼎医药有限公司 | Method for preparing gliclazide |
| CN102924362B (en) * | 2012-10-26 | 2014-12-03 | 浙江工业大学 | Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride |
| CN103601666B (en) * | 2013-11-28 | 2015-09-02 | 遵义医学院 | The preparation method of octahydro pentamethylene [C] pyrroles |
| CN106588746B (en) * | 2016-11-25 | 2019-08-13 | 盘锦格林凯默科技有限公司 | The preparation method of gliclazide side chain and the preparation method of gliclazide |
| CN108084080A (en) * | 2018-01-22 | 2018-05-29 | 安徽金鼎医药股份有限公司 | A kind of preparation method of gliclazide intermediate hexahydro cyclopentano [c] pyrrole radicals -2- amine hydrochlorates |
| CN110372568A (en) * | 2019-08-22 | 2019-10-25 | 山东海佑福瑞达制药有限公司 | A kind of crystallization and preparation method thereof of gliclazide intermediate |
-
2008
- 2008-03-11 CN CN200810060128A patent/CN100591667C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 格列齐特关键中间体顺式-1,2-环戊烷二甲酰亚胺的合成. 张柯华.中国优秀博硕士学位论文全文数据库(博士)医药卫生科技辑,第01期. 2002 * |
| 格列齐特的合成. 梅光明.中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑,第06期. 2006 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101235011A (en) | 2008-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100591667C (en) | N-amino-1,2-cyclopentane dicarboximide and its preparation method | |
| CN106699710B (en) | A kind of lateral tetrafluoro substituted biphenyl and heterocyclic compound and preparation method thereof | |
| CN101333176A (en) | A kind of method that prepares substituted urea to co-produce corresponding amine hydrochloride | |
| CN101381389A (en) | Chemical Synthesis of 5,7-Diene Steroids | |
| CN101337865A (en) | A kind of method for preparing hydroxy calix [4] arene derivatives | |
| Darabi et al. | A novel approach to l-tryptophan grafting on mesoporous MCM-41: A recoverable heterogeneous material for organocatalyzed benzo [N, N]-heterocyclic condensation | |
| CN102414213B (en) | Novel crystal forms of tricyclic benzopyran compound and processes for producing same | |
| CN104311376A (en) | New method for directly preparing aryl aldehyde from aryl nitrile | |
| CN101481333B (en) | Novel rivastigmine preparation | |
| CN100415791C (en) | Preparation method of calixarene[4] modified thermosetting phenolic resin | |
| CN111848473A (en) | A kind of alkenyl sulfide compound and preparation method thereof | |
| CN108164397B (en) | Catechol derivative and its preparation method | |
| CN106187741B (en) | A kind of preparation method of the iodo- l,2,3 benzene tricarboxylic acids of 5- | |
| CN101215241A (en) | Preparation method of 1,4-bis(2,4-diaminophenoxy)benzene | |
| WO2023046046A1 (en) | Hydrogenation synthesis method for preparing pyrazinecarboxylic acid derivative as fluorescent tracer | |
| CN107400083A (en) | A kind of preparation method of 3-[2-(3-chlorophenyl) ethyl]-2-pyridinecarbonitrile | |
| CN110038632B (en) | Preparation of a sulfonic acid functionalized lignin heterogeneous catalyst and a method for synthesizing amide compounds using the catalyst | |
| CN102633708B (en) | Synthesizing and purifying method of midbody 9-(2-ethoxy) carbazole | |
| CN109096226B (en) | Aryl hydrocarbon activation acetoxylation method using 2,1, 3-benzothiadiazole as guide group | |
| CN101265201B (en) | A kind of synthetic method of tramadol hydrochloride | |
| CN111393338A (en) | A kind of dofetilide-d3 medicine and preparation method thereof | |
| CN105801382A (en) | Aryiolefins compound synthetic method | |
| CN101168532B (en) | A kind of synthetic method of N-methylpiperazine substituted aniline | |
| CN105566429B (en) | A kind of preparation method of obeticholic acid type 1 | |
| CN102875388B (en) | Novel method for preparing 9,9-di(4-aminophenyl)fluorene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100224 Termination date: 20110311 |





